Prostate‐specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low‐dose‐rate brachytherapy or external beam radiotherapy for localized prostate cancer

Prostate‐specific antigen nadir (nPSA) after radiotherapy for localized prostate cancer has been investigated as a predictor. However, nPSA usually requires several years, limiting its clinical utility. We investigated the significance of nPSA within 12 months (nPSA12) after low‐dose‐rate prostate b...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Nishimura, Shuichi, Ohashi, Toshio, Momma, Tetsuo, Sakayori, Masanori, Eriguchi, Takahisa, Tanaka, Tomoki, Yamashita, Shoji, Kosaka, Takeo, Oya, Mototsugu, Shigematsu, Naoyuki
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5943430/
https://ncbi.nlm.nih.gov/pubmed/29577651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1443
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky